1023 related articles for article (PubMed ID: 28712855)
1. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.
Tarnow L; Hildebrandt P; Hansen BV; Borch-Johnsen K; Parving HH
Diabetologia; 2005 Jan; 48(1):149-55. PubMed ID: 15616804
[TBL] [Abstract][Full Text] [Related]
6. IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
Hjortebjerg R; Tarnow L; Jorsal A; Parving HH; Rossing P; Bjerre M; Frystyk J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3032-40. PubMed ID: 26046968
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
[TBL] [Abstract][Full Text] [Related]
8. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
9. Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.
Nguyen TQ; Tarnow L; Jorsal A; Oliver N; Roestenberg P; Ito Y; Parving HH; Rossing P; van Nieuwenhoven FA; Goldschmeding R
Diabetes Care; 2008 Jun; 31(6):1177-82. PubMed ID: 18344285
[TBL] [Abstract][Full Text] [Related]
10. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
11. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
13. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
14. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
[TBL] [Abstract][Full Text] [Related]
16. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
[TBL] [Abstract][Full Text] [Related]
17. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
[TBL] [Abstract][Full Text] [Related]
18. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
Lajer M; Tarnow L; Jorsal A; Parving HH
Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.
Gordin D; Forsblom C; Panduru NM; Thomas MC; Bjerre M; Soro-Paavonen A; Tolonen N; Sandholm N; Flyvbjerg A; Harjutsalo V; Groop PH;
Diabetes Care; 2014 Sep; 37(9):2593-600. PubMed ID: 24969575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
